|
STXBP6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.198400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.432500E-02 |
| Normal-vs-Stage2 |
6.935600E-01 |
| Normal-vs-Stage3 |
5.041800E-02 |
| Normal-vs-Stage4 |
9.318900E-03 |
| Stage1-vs-Stage2 |
3.684200E-01 |
| Stage1-vs-Stage3 |
7.479200E-01 |
| Stage1-vs-Stage4 |
4.907800E-01 |
| Stage2-vs-Stage3 |
3.162600E-01 |
| Stage2-vs-Stage4 |
2.677400E-01 |
| Stage3-vs-Stage4 |
7.543400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.215880E-02 |
| Normal-vs-AfricanAmerican |
3.850800E-01 |
| Normal-vs-Asian |
4.513800E-01 |
| Caucasian-vs-AfricanAmerican |
1.414410E-01 |
| Caucasian-vs-Asian |
8.895800E-01 |
| AfricanAmerican-vs-Asian |
2.394800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.093600E-02 |
| Normal-vs-Female |
2.069000E-01 |
| Male-vs-Female |
9.379400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.341400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.662400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.076200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.211840E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.520800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.289800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.905400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.421600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.163400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.053600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.611800E-04 |
| Normal-vs-Grade 2 |
9.323800E-02 |
| Normal-vs-Grade 3 |
1.226320E-02 |
| Normal-vs-Grade 4 |
2.132400E-02 |
| Grade 1-vs-Grade 2 |
1.760210E-01 |
| Grade 1-vs-Grade 3 |
1.807410E-01 |
| Grade 1-vs-Grade 4 |
2.634000E-01 |
| Grade 2-vs-Grade 3 |
7.426600E-01 |
| Grade 2-vs-Grade 4 |
7.160600E-01 |
| Grade 3-vs-Grade 4 |
9.373000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.24199999999675E-05 |
| Normal-vs-ccB subtype |
5.710800E-01 |
| ccA subtype-vs-ccB subtype |
1.262060E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.880100E-02 |
| Normal-vs-N1 |
6.37539999681636E-08 |
| N0-vs-N1 |
2.615300E-04 |
|
|
